Noveome Biotherapeutics
Highly Engaged Employees
Highly Engaged EmployeesChemicals & Related Products · Pennsylvania, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
100 Technology Dr Ste 200, Pittsburgh, P...Phone Number
(412) 402-9914Website
www.noveome.comRevenue
$7.3 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Noveome Biotherapeutics
Noveome Biotherapeutics is advancing its ST266 biologic, a multi-targeted secretome with hundreds of active proteins, for neuroprotection, inflammation modulation, cell recovery, and healing in ophthalmology, neurology, and dermatology fields. They hold rare pediatric disease and orphan drug designations for treating neonatal necrotizing enterocolitis and contribute to fighting against COVID-19. Their groundbreaking science aims to simulate natural healing, offering promising solutions for underserved conditions. Join their passionate team for rewarding careers dedicated to enhancing patients' lives.Explore more
Noveome Biotherapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Noveome Biotherapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Noveome Biotherapeutics is spiking on competitors!
Funding: Get notified immidiatlly once Noveome Biotherapeutics has new funding data
Product Launch: Get notified when Noveome Biotherapeutics launches new products
Earning: See what the market has to say on Noveome Biotherapeutics recently announced quarterly report
Click to see if Noveome Biotherapeutics had a recent Job posting/layoffs
Check if Noveome Biotherapeutics has recently received funding, and reach out quickly before it becomes old news!
Noveome Biotherapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Noveome Biotherapeutics
Recommended Actions
Reach out to Masked Content who joined Noveome Biotherapeutics as Masked Content
Find more new buyers
Compare Similar Companies to Noveome Biotherapeutics
Compare insights from companies similar to Noveome Biotherapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Noveome Biotherapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Noveome Biotherapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Noveome Biotherapeutics.
Noveome Biotherapeutics financials insights
Gather financial insights about Noveome Biotherapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2016
Series A
$2.2M
2019
Series D
$15M
2020
Debt
$350K
2021
Debt
$666K
2023
Series E
$40.2M
2026
Debt
$6.8M
Noveome Biotherapeutics Tech Stack
A closer look at the technologies used by Noveome Biotherapeutics
See more technologies
Most Recent Scoops
Funding
Executive Move
Board of Directors
Executive Move
Board of Directors
New Hire
Executive Move
Lateral Move
Executive Move
Top Chemicals & Related Products Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Noveome Biotherapeutics
Sign Up For FreeTo access detailed company insights
Noveome Biotherapeutics is advancing its ST266 biologic, a multi-targeted secretome with hundreds of active proteins, for neuroprotection, inflammation modulation, cell recovery, and healing in ophthalmology, neurology, and dermatology fields. They hold rare pediatric disease and orphan drug designations for treating neonatal necrotizing enterocoli... Read More
